Dermatan sulfate-low molecular weight - Alfa Wassermann/Opocrin

Drug Profile

Dermatan sulfate-low molecular weight - Alfa Wassermann/Opocrin

Alternative Names: D 370; Desmin; Desmin 370; Low molecular weight dermatan sulfate

Latest Information Update: 28 May 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Alfa Wassermann Inc; Opocrin
  • Class Antithrombotics
  • Mechanism of Action Glycosaminoglycan stimulants; Thrombin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Deep vein thrombosis

Most Recent Events

  • 30 Jan 2001 Phase-III clinical trials for Deep vein thrombosis in Europe (IM)
  • 24 Aug 1998 A clinical study has been added to the pharmacokinetics and Thromboses pharmacodynamics sections
  • 22 Jun 1998 Investigation in Deep vein thrombosis in Europe (IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top